Steris | STE - Cost Of Sales

Stock Price
252.16
Daily Change
8.35 3.42%
Monthly
-2.72%
Yearly
12.96%
Q1 Forecast
254.51

Steris reported $840.7M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
3M USD 4.08B 283M Dec/2025
Avanos Medical USD 91.8M 8.9M Sep/2025
Baxter International USD 1.88B 66M Sep/2025
Becton, Dickinson and Co. USD 5.19B 2.32B Sep/2025
Boston Scientific USD 1.84B 82M Dec/2025
CONMED USD 154.91M 16.9M Dec/2025
Cooper Companies USD 464.2M 45.9M Sep/2025
Dexcom USD 477.9M 9.6M Sep/2025
Ecolab USD 2.3B 79.1M Sep/2025
Edwards Lifesciences USD 345.2M 800K Sep/2025
Fortive USD 413.6M 35.7M Dec/2025
Getinge SEK 6.02B 1.7B Dec/2024
Globus Medical USD 282.38M 3.42M Sep/2025
Haemonetics USD 136.58M 4.01M Dec/2025
Hologic USD 463.7M 5.1M Dec/2025
Idexx Laboratories USD 432.46M 10.58M Dec/2025
Insulet USD 196.2M 700K Sep/2025
Integra LifeSciences USD 195.07M 11.2M Sep/2025
Intuitive Surgical USD 961.9M 119.2M Dec/2025
J&J USD 7.97B 689M Dec/2025
Masimo USD 140.9M 3.3M Sep/2025
Olympus JPY 86.54B 15.15B Sep/2025
Owens Minor USD 2.11B 10.27M Mar/2025
ResMed USD 555.85M 29.13M Dec/2025
Steris USD 840.7M 26.3M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Tandem Diabetes Care USD 114.96M 138K Sep/2025
Teleflex USD 461.38M 111.57M Sep/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Zimmer Biomet Holdings USD 735.8M 17M Sep/2025